EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis
Sponsor: Katie Larson Ode
This NA trial investigates Cystic Fibrosis-related Diabetes and is currently completed. Katie Larson Ode leads this study, which shows 12 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Jan 2025 — Sep 2025 [monthly]
Completed NA
-
Oct 2024 — Jan 2025 [monthly]
Completed NA
-
Sep 2024 — Oct 2024 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
-
Apr 2023 — Dec 2023 [monthly]
Enrolling By Invitation NA
Status: Active Not Recruiting → Enrolling By Invitation
-
Jan 2022 — Apr 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jan 2022 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
-
Sep 2018 — Feb 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Katie Larson Ode
For direct contact, visit the study record on ClinicalTrials.gov .